This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. British media are reporting that vaccinations with the human ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. For the record: An earlier version of this story and its headline ...

The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated ...

Cervarix has not yet received U.S. approval. Merck's Gardisil -- approved last year -- is currently the only cervical cancer vaccine on the U.S. market. Latest Headlines.

GlaxoSmithKline PLC's Cervarix vaccine induced a higher immune response in women against the virus that causes cervical cancer than Merck & Co.'s Gardasil, according to a Glaxo-funded clinical ...

WASHINGTON -- The Food and Drug Administration said Friday that Merck & Co.'s Gardasil vaccine against cervical cancer was also effective at preventing genital warts in males. Separately, the FDA ...

Cervarix: the simple injection causing so much controversy. The cervical cancer jab Cervarix is currently under scrutiny after nearly 1,500 Britons have experienced adverse reactions to it.

And the Academy Award for Best Performance by a Vaccine in the Unbranded Category goes to… Cervarix! Forget Avatar vs. Hurt Locker, GlaxoSmithKline scored big on Oscar night with its own hit—an ...

Cervarix has been shown to target two viruses that account for 70 percent of all cases of cervical cancer. - read this report from the Independent for more.

SAN FRANCISCO (MarketWatch) -- GlaxoSmithKline Plc GSK, -1.04% on Friday said mathematical data shows that its Cervarix vaccine candidate against types 16 and 18 of cervical cancer may prevent 80% ...

Cervarix however has yet to be approved in the US and likely won’t be until 2008, since the vaccine was only submitted for approval in March. Although Gardasil has an early lead in the key US market, ...

LONDON (MarketWatch) -- Drug maker GlaxoSmithKline PLC GSK Monday said Cervarix, a cervical cancer vaccine expected to become a multibillion-dollar product, has been approved by health regulators ...